- $8.1 BnWorld market, 2023
- $24.7 BnProjected, 2033
- 11.8%Growth a year (CAGR)
- 324Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$3.4 Bn
9.8% a year · 42% of the world -
2
China
$651 Mn
13.3% a year · 8% of the world -
3
Canada
$648 Mn
11.8% a year · 8% of the world -
4
Japan
$504 Mn
12.3% a year · 6.2% of the world -
5
Germany
$297 Mn
10% a year · 3.7% of the world -
6
France
$223 Mn
10.8% a year · 2.8% of the world -
7
UK
$211 Mn
9.8% a year · 2.6% of the world -
8
Brazil
$203 Mn
12.8% a year · 2.5% of the world -
9
Italy
$194 Mn
11.3% a year · 2.4% of the world -
10
Ecuador
$162 Mn
12.4% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)Prebiotics by country and region
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $8.1 Bn | $24.7 Bn | 11.8% | – | 324 | Report on Prebiotics in Global |
| North America | $4.1 Bn | $11.3 Bn | 10.8% | 50% | 97 | Report on Prebiotics in North America |
| APAC | $1.7 Bn | $5.8 Bn | 13.1% | 21% | 58 | Report on Prebiotics in APAC |
| Europe | $1.5 Bn | $4.2 Bn | 10.5% | 19% | 62 | Report on Prebiotics in Europe |
| Latin America | $365 Mn | $1.2 Bn | 12.8% | 4.5% | 11 | Report on Prebiotics in Latin America |
| Middle East | $324 Mn | $1.1 Bn | 12.8% | 4% | 1 | Report on Prebiotics in Middle East |
| Africa | $122 Mn | $424 Mn | 13.3% | 1.5% | 4 | Report on Prebiotics in Africa |
| US |
$3.4 Bn | $8.7 Bn | 9.8% | 42% | 77 | Report on Prebiotics in US |
| China |
$651 Mn | $2.3 Bn | 13.3% | 8% | 37 | Report on Prebiotics in China |
| Canada |
$648 Mn | $2 Bn | 11.8% | 8% | 20 | Report on Prebiotics in Canada |
| Japan |
$504 Mn | $1.6 Bn | 12.3% | 6.2% | 0 | Report on Prebiotics in Japan |
| Germany |
$297 Mn | $769 Mn | 10% | 3.7% | 12 | Report on Prebiotics in Germany |
| France |
$223 Mn | $621 Mn | 10.8% | 2.8% | 12 | Report on Prebiotics in France |
| UK |
$211 Mn | $536 Mn | 9.8% | 2.6% | 19 | Report on Prebiotics in UK |
| Brazil |
$203 Mn | $675 Mn | 12.8% | 2.5% | 1 | Report on Prebiotics in Brazil |
| Italy |
$194 Mn | $567 Mn | 11.3% | 2.4% | 12 | Report on Prebiotics in Italy |
| Ecuador |
$162 Mn | $523 Mn | 12.4% | 2% | 0 | Report on Prebiotics in Ecuador |
 Spain |
$156 Mn | $436 Mn | 10.8% | 1.9% | 6 | Report on Prebiotics in Spain |
 India |
$147 Mn | $586 Mn | 14.8% | 1.8% | 6 | Report on Prebiotics in India |
 Saudi Arabia |
$138 Mn | $480 Mn | 13.3% | 1.7% | 1 | Report on Prebiotics in Saudi Arabia |
 Mexico |
$122 Mn | $379 Mn | 12.1% | 1.5% | 10 | Report on Prebiotics in Mexico |
 Australia |
$97 Mn | $339 Mn | 13.3% | 1.2% | 1 | Report on Prebiotics in Australia |
 South Africa |
$53 Mn | $179 Mn | 13% | 0.6% | 1 | Report on Prebiotics in South Africa |
 UAE |
$41 Mn | $135 Mn | 12.8% | 0.5% | 0 | Report on Prebiotics in UAE |
 Egypt |
$23 Mn | $79 Mn | 13.3% | 0.3% | 3 | Report on Prebiotics in Egypt |
 Philippines |
$18 Mn | $57 Mn | 12.3% | 0.2% | 1 | Report on Prebiotics in Philippines |
 Hong Kong |
$13 Mn | $43 Mn | 12.8% | 0.2% | 6 | Report on Prebiotics in Hong Kong |
 Malaysia |
$13 Mn | $40 Mn | 12% | 0.2% | 2 | Report on Prebiotics in Malaysia |
 Singapore |
$10 Mn | $31 Mn | 12.4% | 0.1% | 3 | Report on Prebiotics in Singapore |
 Thailand |
$10 Mn | $31 Mn | 12.1% | 0.1% | 2 | Report on Prebiotics in Thailand |
 Kenya |
$6 Mn | $19 Mn | 12.9% | 0.1% | 0 | Report on Prebiotics in Kenya |
 New Zealand |
– | – | – | – | 1 | Report on Prebiotics in New Zealand |
 Russia |
– | – | – | – | 3 | Report on Prebiotics in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 12,869 papers since 2021
- Critical advances and translational bottlenecks of gut microbiota-gut-brain axis targeted therapy for neurodegenerative and neurodevelopmental disorders. Journal of neuroimmunology, 2026
- Temporal Dynamics of the Faecal Microbiota and Physiological Responses to Phytobiotics and Organic Acids in Broiler Chickens. Journal of animal physiology and animal nutrition, 2026
- From Dysbiosis to Vascular Disease: the Gut Microbiota in Type 2 Diabetes and Atherosclerosis. Current atherosclerosis reports, 2026
- Synbiotic Kefir-Yacon Drink Ameliorates Hypertension by Modulating Antioxidant and Anti-Inflammatory Pathways. Journal of food science, 2026
- Microbiome-Targeted Interventions for Pediatric Asthma and Allergic Diseases: Current and Emerging Approaches. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2026
Compare Prebiotics side by side
Key companies in Prebiotics
Gobiotics NV
Roquette Freres
Archer-Daniels-Midland Company
Yakult Honsha Co Ltd
Kerry Group Inc
Groupe Warcoing SA
Cargill, Incorporated
Sensus BV
International Flavours & Fragrances
Quick answers
How big is the Prebiotics market?
The world Prebiotics market was worth about $8.1 Bn in 2023 and is projected to reach $24.7 Bn by 2033, growing 11.8% a year (CAGR).
Which country has the largest Prebiotics market?
The US is the largest of the 24 countries we cover, at $3.4 Bn in 2023. India grows fastest, at 14.8% a year.
How many clinical trials are running in Prebiotics?
ClinicalTrials.gov lists 324 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Prebiotics?
PubMed lists about 12,869 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.